How Health Plan Leaders Are Handling the GLP-1 Cost Crisis [Survey Report]
Results from New Executive Survey on GLP-1 Cost Crisis
A new survey of 80 Chief Medical Officers, Chief Pharmacy Officers and actuarial leaders shines a light on the growing GLP-1 cost crisis. Read this report to find out why 4 out of 5 senior executives are significantly concerned about GLP-1 utilization and cost growth, including:
- Why executives expect this cost crisis to last for the rest of the decade and spread from obesity to type 2 diabetes indications
- What executives are doing to protect their organizations from the GLP-1 cost surge
- Why leaders are turning towards provider-led lifestyle programs to address obesity with and without GLP-1s
How Health Plan Leaders Are Handling the GLP-1 Cost Crisis [Survey Report]
Results from New Executive Survey on GLP-1 Cost Crisis
A new survey of 80 Chief Medical Officers, Chief Pharmacy Officers and actuarial leaders shines a light on the growing GLP-1 cost crisis. Read this report to find out why 4 out of 5 senior executives are significantly concerned about GLP-1 utilization and cost growth, including:
- Why executives expect this cost crisis to last for the rest of the decade and spread from obesity to type 2 diabetes indications
- What executives are doing to protect their organizations from the GLP-1 cost surge
- Why leaders are turning towards provider-led lifestyle programs to address obesity with and without GLP-1s
Read the report
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.